Bo Ren

Bo Ren

Auto-generated profile, based on publicly available information

Bo Ren

Honghui Hospital Affiliated to Xi’an Jiaotong University, Xi’an, China

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 June 2017 in Advanced Materials
Verified
Journal Article
Closed access
PDF file
WSWeili Shi
Weili Shi
MSMuyang Sun
Muyang Sun
XHXiaoqing Hu
Xiaoqing Hu
BRBo Ren
Bo Ren
JCJin Cheng
Jin Cheng
YAYingfang Ao
Yingfang Ao

9 April 2019 in Arthroscopy
Verified
Journal Article
Closed access
MZMingyu Zhang
Mingyu Zhang
JZJiang Zhen
Jiang Zhen
XZXian Zhang
Xian Zhang
ZYZhen Yang
Zhen Yang
LZLiang Zhang
Liang Zhang
BRBo Ren
Bo Ren

1 August 2019 in Archives of orthopaedic and trauma surgery
Verified
Journal Article
Closed access
BRBo Ren
Bo Ren
XZXian Zhang
Xian Zhang
LZLiang Zhang
Liang Zhang
MZMingyu Zhang
Mingyu Zhang
YLYang Liu
Yang Liu
JZJiang Zheng
Jiang Zheng

1 August 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
CLChenxi Li
Chenxi Li
XHXiaoqing Hu
Xiaoqing Hu
QMQingyang Meng
Qingyang Meng
XZXin Zhang
Xin Zhang
JZJingxian Zhu
Jingxian Zhu
YAYingfang Ao
Yingfang Ao
Since transplantation of meniscal allograft or artificial menisci is limited by graft sources and a series of adverse events, substitution for meniscus reconstruction still needs to be explored. Natural biomaterials, which can provide a unique 3-D microenvironment, remain a promising alternative for tissue engineering. Among them, autograft is a preferred option for its safety and excellent biocompatibility. In this study, we utilized semitendinosus tendon autograft in meniscus reconstruction to investigate its fibrochondrogenic metaplasticity potential and chondroprotective effect. Tendon-derived stem cells (TDSCs) and synovial-derived mesenchymal stem cells (SMSCs), two most important stem cell sources in our strategy, exhibited excellent viability, distribution, proliferation and fibrochondrogenic differentiation ability in decellularized semitendinosus tendon (DST) scaffolds in vitro. Histologic evaluation of the tendon grafts in vivo suggested endogenous stem cells differentiated into fibrochondrocytes, synthesized proteoglycan, type II collagen and radial type I collagen at 12 weeks and 24 weeks post-surgery. As for elastic modulus and hardness of the grafts, there were no significant differences between native meniscus and regenerated meniscus at 24 weeks. The protection of condylar cartilage from degeneration was significantly better in the reconstruction group comparing to control group. Overall, semitendinosus tendon autograft seems to be a promising substitution in meniscus reconstruction.

29 September 2016 in Scientific Reports
Verified
Journal Article
Open access
PDF file
JCJin Cheng
Jin Cheng
XHXiaoqing Hu
Xiaoqing Hu
LDLinghui Dai
Linghui Dai
XZXin Zhang
Xin Zhang
BRBo Ren
Bo Ren
YAYingfang Ao
Yingfang Ao
Osteoarthritis (OA) is a common debilitating joint disorder, there’s still no available disease-modifying drug for OA currently. This study aims to explore the role of TAK1 in OA pathogenesis and therapeutic efficiency of TAK1 inhibition for OA. The contribution of TAK1 to OA pathogenesis was investigated by intra-articular injection of TAK1-encoding adenovirus in rats. TAK1 inhibitor 5Z-7-induced expression changes of extracellular matrix (ECM)-related genes were detected by real-time PCR. The protective effect of 5Z-7 against OA progression was evaluated in a post-traumatic OA rat model. Our results showed that intra-articular injection of Ad-Tak1 induced cartilage destruction and OA-related cytokine secretion in rat joints. TAK1 inhibition by 5Z-7 efficiently blocked NF-κB, JNK and p38 pathways activation in OA chondrocytes and synoviocytes, Meanwhile, 5Z-7 significantly decreased the expression of matrix-degrading enzymes and pro-inflammatory cytokine, while increased ECM protein expression, which are all crucial components in OA. 5Z-7 also ameliorated ECM loss in OA cartilage explants. More importantly, 5Z-7 significantly protected against cartilage destruction in a rat model of OA. In conclusion, our findings provide the first in vivo evidence that TAK1 contributes to OA by disrupting cartilage homeostasis, thus represents an ideal target for OA treatment, with 5Z-7 as a candidate therapeutic.

7 July 2021 in International journal of legal medicine
Verified
Journal Article
Closed access
PDF file
TLTing Lu
Ting Lu
LQLi-Rong Qiu
Li-Rong Qiu
BRBo Ren
Bo Ren
LSLei Shi
Lei Shi
FFFei Fan
Fei Fan
ZDZhen-Hua Deng
Zhen-Hua Deng